Text size A A

At AGTC we are currently conducting clinical studies for the treatment of multiple blinding genetic conditions.

For additional information about gene therapy, inherited retinal conditions and our clinical trials, view our Clinical Study Resource or contact us at advocacy@agtc.com

XLRSX-linked Retinoschisis

Currently Enrolling Patients join now

AGTC is currently conducting a clinical study to evaluate the safety and efficacy of an investigational gene therapy in patients with XLRS.

Status: This study is currently recruiting. For more information, and to see whether you or someone you know qualifies to join the study, visit ClinicalTrials.Gov or email us at advocacy@agtc.com

Sites
  • University of California San Francisco, Dept. of Ophthalmology
  • The Wilmer Eye Institute, Johns Hopkins Hospital
  • Massachusetts Eye and Ear Infirmary
  • University of Michigan Kellogg Eye Center
  • Casey Eye Institute, Oregon Health and Sciences University
  • Retina Foundation of the Southwest
  • Baylor College of Medicine, Alkek Eye Center

 

ACHM B3Achromatopsia

Currently Enrolling Patients join now

AGTC is currently conducting a clinical study to evaluate the safety and efficacy of an investigational gene therapy in patients with XLRS.

Status: This study is currently recruiting. For more information, and to see whether you or someone you know qualifies to join the study, visit ClinicalTrials.Gov or email us at advocacy@agtc.com

Sites
  • VitreoRetinal Associates
  • Bascom Palmer Eye Institute
  • Pangere Center for Inherited Retinal Diseases, The Chicago Lighthouse for People Who Are Blind or Visually Impaired
  • Casey Eye Institute, Oregon Health and Sciences University

ACHM A3Achromatopsia

Currently Enrolling Patients join now

AGTC is currently conducting a clinical study to evaluate the safety and efficacy of an investigational gene therapy in patients with XLRS.

Status: This study is currently recruiting. For more information, and to see whether you or someone you know qualifies to join the study, visit ClinicalTrials.Gov or email us at advocacy@agtc.com

Sites
  • VitreoRetinal Associates
  • Bascom Palmer Eye Institute
  • Massachusetts Eye and Ear Infirmary
  • Casey Eye Institute, Oregon Health and Sciences University
  • University of Pennsylvania
  • Hadassah-Hebrew University Medical Center

XLRPX-linked Retinitis Pigmentosa

Currently Enrolling Patients join now

AGTC is currently conducting a clinical study to evaluate the safety and efficacy of an investigational gene therapy in patients with XLRP.

Status: This study is currently recruiting. For more information, and to see whether you or someone you know qualifies to join the study, visit ClinicalTrials.Gov or email us at advocacy@agtc.com

Sites
  • Casey Eye Institute, Oregon Health and Sciences University
  • University of Pennsylvania/Wills Eye Hospital
  • Retina Foundation of the Southwest
  • Duke University
  • Columbia University
  • Cincinnati Eye Institute
Visionary science for life changing cures.